Non-recommended medical interventions and their possible harm in patients with COVID-19

Documento (106.8Kb)
application/pdf
application/pdf
Date
2021Author(s)
Pecho-Silva, S.
Navarro-Solsol, A.C.
Panduro-Correa, V.
Rabaan, A.A.
Bonilla-Aldana, D.K.
Rodríguez-Morales, A.J.
Arteaga-Livias, K.
Metadata
Show full item recordAbstract
The disease caused by the SARS-CoV-2 virus (COVID-19) can manifest itself through more than 80 symptoms and signs, considering it a multisystemic disease.1 However, the disease is classified according to the pulmonary involvement evaluated through the measurement of the respiratory rate, respiratory signs and symptoms, oxygen saturation (SatO2), the ratio of arterial oxygen pressure to inspired oxygen fraction (PaO2/FiO2), and the extent of lung lesions seen on non-contrast chest tomography. The leading cause of death among patients with severe and critical COVID-19 is diffuse alveolar damage, a histopathological manifestation of Acute Respiratory Distress Syndrome (ARDS).
